Advertisement

111, Inc. YI

Set alert

Price alert · YI

All alert types
2.85 USD -0.15 -5.00%

At close · Oct 30

2.92 +0.07 +2.46%

After hours · Oct 30, 4:00 PM ET

Bid
2.75 × 2
Ask
3.04 × 2
2.85 Day range 2.94
2.56 52-week range 8.38
YTD
+11.33%
1 year
-35.08%
Open
2.94
Prev close
3.00
Mkt cap
25.07M
Vol
21.64K
Avg vol
13.88K
EPS
10.26
P/E
0.28
Div yield
0.00%
More statistics
Low
2.85
High
2.94
Forward P/E
5.29
Beta
0.39
Short ratio
0.25
Inst. own
23.89%
Dividend
0.00
Ex-div date
50-d avg
0.7526
200-d avg
0.9771
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 27, 2024Earnings: -0.02; estimate 0; surprise —%
  • Jan 24, 2025Split: 1 for 10
Signals (77)
NameDateAgo
MACD: Sell SignalOct 23, 20261 week ago
RSI: OversoldOct 23, 20261 week ago
MACD: Buy SignalOct 20, 20261 week ago
MACD: Sell SignalOct 1, 20261 month ago
SMA: BearishSep 24, 20261 month ago
SMA: BullishSep 23, 20261 month ago
SMA: BearishSep 22, 20261 month ago
SMA: BullishSep 21, 20261 month ago
MACD: Buy SignalSep 11, 20261 month ago
MACD: Sell SignalAug 31, 20262 months ago
MACD: Buy SignalAug 25, 20262 months ago
MACD: Sell SignalAug 19, 20262 months ago
MACD: Buy SignalJun 29, 20264 months ago
RSI: OversoldJun 22, 20264 months ago
RSI: OversoldJun 9, 20264 months ago
RSI: OversoldJun 4, 20264 months ago
SMA: BearishMay 26, 20265 months ago
SMA: BullishMay 22, 20265 months ago
SMA: BearishMay 21, 20265 months ago
SMA: BullishMay 8, 20265 months ago
SMA: BearishMay 7, 20265 months ago
MACD: Sell SignalApr 30, 20266 months ago
MACD: Buy SignalApr 10, 20266 months ago
SMA: BearishMar 23, 20267 months ago
SMA: BullishMar 20, 20267 months ago
SMA: BearishMar 19, 20267 months ago
MACD: Sell SignalFeb 20, 20268 months ago
RSI: OverboughtFeb 10, 20268 months ago
SMA: BullishJan 30, 20269 months ago
RSI: OverboughtJan 30, 20269 months ago
RSI: OverboughtJan 13, 20269 months ago
SMA: BullishJan 12, 20269 months ago
MACD: Buy SignalJan 9, 20269 months ago
RSI: OversoldDec 29, 202510 months ago
RSI: OversoldDec 23, 202510 months ago
MACD: Sell SignalDec 22, 202510 months ago
MACD: Buy SignalDec 1, 202511 months ago
MACD: Sell SignalNov 17, 202511 months ago
RSI: OversoldNov 17, 202511 months ago
RSI: OversoldNov 11, 202511 months ago
RSI: OversoldOct 17, 20251 year ago
RSI: OversoldOct 14, 20251 year ago
RSI: OversoldOct 10, 20251 year ago
MACD: Buy SignalOct 7, 20251 year ago
RSI: OversoldSep 19, 20251 year ago
RSI: OversoldSep 4, 20251 year ago
SMA: BearishSep 3, 20251 year ago
MACD: Sell SignalSep 2, 20251 year ago
SMA: BearishAug 21, 20251 year ago
SMA: BullishAug 20, 20251 year ago
MACD: Buy SignalAug 18, 20251 year ago
RSI: OversoldAug 13, 20251 year ago
MACD: Sell SignalJul 28, 20251 year ago
MACD: Buy SignalJul 10, 20251 year ago
SMA: BearishJun 23, 20251 year ago
SMA: BullishJun 12, 20251 year ago
SMA: BearishJun 11, 20251 year ago
MACD: Sell SignalJun 11, 20251 year ago
SMA: BullishMay 29, 20251 year ago
MACD: Buy SignalMay 27, 20251 year ago
MACD: Sell SignalMay 7, 20251 year ago
SMA: BearishApr 25, 20251 year ago
SMA: BullishApr 22, 20251 year ago
MACD: Buy SignalApr 22, 20251 year ago
SMA: BearishApr 4, 20251 year ago
MACD: Sell SignalMar 26, 20251 year ago
RSI: OverboughtMar 21, 20251 year ago
MACD: Buy SignalMar 19, 20251 year ago
RSI: OverboughtMar 17, 20251 year ago
MACD: Sell SignalFeb 24, 20251 year ago
SMA: BullishJan 24, 20251 year ago
MACD: Buy SignalJan 24, 20251 year ago
RSI: OverboughtJan 24, 20251 year ago
RSI: OversoldJan 13, 20251 year ago
MACD: Sell SignalDec 23, 20241 year ago
MACD: Buy SignalDec 20, 20241 year ago
RSI: OverboughtNov 27, 20241 year ago

Key statistics

Market cap
63.40M
Enterprise value
618.31M
Trailing P/E
0.00
Forward P/E
5.29
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
EPS (TTM)
-0.41
Beta
0.39
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-2.25%
Revenue (TTM)
14.73B
Revenue growth
-1.50%
Free cash flow
359.45M
Total cash
595.45M
Total debt
245.54M
Return on equity
-66.14%
Shares outstanding
49.66M
Short % of float
0.07%
50-day average
0.7526
200-day average
0.9771

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
YI Revenue — quarterly 2.30B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
YI Net income — quarterly -39.13M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

YI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 27, 2024Sep 1, 20240.00-0.02——
Aug 29, 2024Jun 1, 20240.00-0.02——
May 23, 2024Mar 1, 20240.00-0.02——
Mar 21, 2024Dec 1, 20230.00-0.34——
Nov 30, 2023Sep 1, 20230.00-0.16——
Aug 24, 2023Jun 1, 20230.00-0.10——

About 111, Inc.

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates in two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. The company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangdong, Guangzhou, Tianjin, and Kunshan. It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Sector
Healthcare
Industry
Medical Distribution
Country
China

News

Your note

Sign in to keep a note on YI — it syncs with the Stock Master app.

Institution ownership

YI institution ownership
Holder% heldSharesValueReported
Renaissance Technologies, LLC0.27%134,24799.36KSep 29, 2024
Morgan Stanley0.10%51,66838.24KSep 29, 2024
Citadel Advisors Llc0.08%41,92731.03KSep 29, 2024
Geode Capital Management, LLC0.07%33,10024.50KSep 29, 2024
Xtx Topco Ltd0.06%31,12323.03KSep 29, 2024
HRT Financial LP0.03%15,02811.12KSep 29, 2024

Fund ownership

YI fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.07%33,10024.50KOct 30, 2024
Advertisement